Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Debt / NOTE 5.250%12/0
-
Number of holders
-
7
-
Total principal
-
87.5M
-
Principal change
-
0
-
Total reported value, excl. options
-
$145M
-
Value change
-
-$14.1K
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$1.63
Significant Holders of LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 as of Q3 2017
7 filings reported holding 528872AB0 - LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 as of Q3 2017.
LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 has 7 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $87.5M of principal
.
Largest 8 bondholders include CITADEL ADVISORS LLC ($31.8M of principal), Polygon Management Ltd. ($17.5M of principal), LAZARD ASSET MANAGEMENT LLC ($12.5M of principal), WOLVERINE ASSET MANAGEMENT LLC ($12.3M of principal), UBS ASSET MANAGEMENT AMERICAS INC ($10M of principal), JPMORGAN CHASE & CO ($3.32M of principal), MACKAY SHIELDS LLC ($127K of principal), and Clearbridge Investments, LLC ($0 of principal).
This table shows the top 7 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.